Life sciences training leaders Jennifer Bryan and Mark Lockett have been selected to join the LTEN Board of Directors. Their appointments begin immediately.
Bryan, Head of Commercial Training & Development for Teva Pharmaceuticals, has been in life sciences since starting as a representative in 2001. At Teva, she’s held roles including National Sales Trainer, Senior Training Manager, Associate Director of Strategic Operations and Learning Technology and Director of Therapeutic Training. Bryan has been an LTEN member since 2011.
Lockett, Head of Commercial Training and Leadership Development for Sanofi Genzyme, has held many roles in life sciences, for companies including Johnson & Johnson, Biogen, Medivation, Intarcia Therapeutics and Verastem Oncology. He’s been working in training and leadership development roles since 2005 and joined LTEN in 2016.
“Mark and Jenny are great additions to the LTEN Board,” said Dawn Brehm, LTEN executive director. “Both have been active, involved members since they joined LTEN. Mark and Jenny bring impressive knowledge and experience to their new Board roles, along with a strong commitment to LTEN. Their contributions will make our network stronger.”
The Life Sciences Trainers & Educators Network (www.L-TEN.org) is the only global 501(c)(3) nonprofit organization specializing in meeting the needs of life sciences learning professionals. LTEN shares the knowledge of industry leaders, provides insight into new technologies, offers innovative solutions and communities of practice that grow careers and organizational capabilities. Founded in 1971, LTEN has grown to more than 2,100 individual members who work in pharmaceutical, biotech, medical device and diagnostic companies, and industry partners who support the life sciences training departments.
For more information contact Nannette Nolan, LTEN director of marketing communications, at nnolan@L-TEN.org.